Ascendis Pharma A/S (ASND)

Ascendis Pharma Revenue

Ascendis Pharma had revenue of $357.63M in the twelve months ending March 31, 2024, with 322.18% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $104.23M with 185.49% year-over-year growth. In the year 2023, Ascendis Pharma had annual revenue of $296.35M with 444.36% growth.

• Revenue (ttm): $357.63M
• Revenue Growth: +322.18%
• P/S Ratio: 21.40
• Revenue / Employee: $406,864
• Employees: 879
• Market Cap: 7.65B USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	296.35M	241.91M	444.36%
Dec 31, 2022	54.44M	45.60M	515.94%
Dec 31, 2021	8.84M	359.37K	4.24%
Dec 31, 2020	8.48M	-6.55M	-43.58%
Dec 31, 2019	15.03M	2.87M	23.57%
Dec 31, 2018	12.16M	10.33M	562.40%
Dec 31, 2017	1.84M	-3.01M	-62.12%
Dec 31, 2016	4.85M	-3.97M	-45.02%
Dec 31, 2015	8.82M	-8.10M	-47.89%
Dec 31, 2014	16.92M	-11.15M	-39.71%
Dec 31, 2013	28.06M	7.51M	36.53%
Dec 31, 2012	20.56M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.